GURU
Global X Funds - Global X Guru Index ETF

219
Loading...
Loading...
News
all
press releases
News Placeholder
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?
Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.
Stocktwits·9mo ago

Latest GURU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.